Savr V. Bugurov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Savr V. Bugurov has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Olesia S. Osipova
National Medical Research Center named after Academician E.N. Meshalkin, Ministry of Health of the Russian Federation, 630055, Novosibirsk, Russian Federation
8 shared publications - Alexander A. Gostev
Meshalkin National Medical Research Center
7 shared publications - Alexey V. Cheban
Meshalkin National Medical Research Center Novosibirsk Russian Federation
7 shared publications - Pavel V. Ignatenko
Meshalkin National Medical Research Center
7 shared publications - Andrey A. Karpenko
Meshalkin National Medical Research Center
6 shared publications - Shoraan B. Saaya
Meshalkin National Medical Research Center
6 shared publications
Latest Publications
- Open Access
- 28 April 2025
- Published by Meshalkin National Medical Research Center in Patologiya krovoobrashcheniya i kardiokhirurgiya
- Vol. 29 (1) , 7-17
Asymptomatic cerebral ischemia after carotid artery stenting as a predictor of cognitive impairment
Objective: The study aimed to compare cognitive functions in patients with asymptomatic cerebral ischemic lesions and without cerebral ischemic lesions after carotid artery stenting (CAS). Methods: A prospective cohort study was based on a subanalysis of 100 patients from the SIBERIA study database who underwent CAS. Patients with a history of stroke or contralateral occlusion of the internal carotid artery, with the development of a vascular event or death during 12 months of follow-up, and individuals with lost contacts were excluded from the analysis. Patients completed the MMSE (Mini-Mental State Examination) test before and after CAS stenting at 6 and 12 months. All three tests were completed by 39 patients with asymptomatic cerebral ischemic lesions and 36 patients without cerebral ischemic lesions on diffusion-weighted magnetic resonance imaging (MRI) of the brain in the early postoperative period after CAS. Pseudo-randomization was performed in a 1:1 ratio using the propensity score matching method, after which 30 patients were included in each group. The primary endpoint was the development of predementia/dementia. Results: In the group patients with asymptomatic cerebral ischemic lesions, both a significantly lower median score on the MMSE test (26 [25; 28] versus 28 [28; 29], p < 0.001) and a greater number of patients with dementia/predementia (18 (60%) versus 7 (23.3%), p = 0.008) were found compared with the control group in 12 months after CAS. Asymptomatic cerebral ischemic lesions increased the risk of developing predementia/dementia within 12 months after CAS (RR 2.57 [1.07; 6.15], p = 0.02). The total volume of asymptomatic cerebral ischemic lesions ≥ 78 mm3 predicted a decline in cognitive functions. Conclusion: Asymptomatic cerebral ischemic lesions after CAS significantly increased the risk of developing cognitive impairment during 12 months after procedure. Received 20 February 2025. Revised 6 March 2025. Accepted 7 March 2025. FundingThe study did not have sponsorship. Conflict of interestThe authors declare no conflict of interest. Contribution of the authorsConception and study design: O.S. Osipova,A.A. Gostev, S.V. Bugurov, P.V. Ignatenko, A.M. ChernyavskiyData collection and analysis: O.S. Osipova, A.A. Gostev, S.V. BugurovStatistical analysis: O.S. Osipova, A.A. Gostev, S.V. BugurovDrafting the article: O.S. Osipova, A.A. GostevCritical revision of the article: P.V. Ignatenko,A.M. ChernyavskiyFinal approval of the version to be published: O.S. Osipova, A.A. Gostev, S.V. Bugurov, P.V. Ignatenko, A.M. Chernyavskiy
- 28 April 2025
- Published by Meshalkin National Medical Research Center in Patologiya krovoobrashcheniya i kardiokhirurgiya
- Vol. 29 (1) , 7-17
Open AccessAsymptomatic cerebral ischemia after carotid artery stenting as a predictor of cognitive impairment
Objective: The study aimed to compare cognitive functions in patients with asymptomatic cerebral ischemic lesions and without cerebral ischemic lesions after carotid artery stenting (CAS). Methods: A prospective cohort study was based on a subanalysis of 100 patients from the SIBERIA study database who underwent CAS. Patients with a history of stroke or contralateral occlusion of the internal carotid artery, with the development of a vascular event or death during 12 months of follow-up, and individuals with lost contacts were excluded from the analysis. Patients completed the MMSE (Mini-Mental State Examination) test before and after CAS stenting at 6 and 12 months. All three tests were completed by 39 patients with asymptomatic cerebral ischemic lesions and 36 patients without cerebral ischemic lesions on diffusion-weighted magnetic resonance imaging (MRI) of the brain in the early postoperative period after CAS. Pseudo-randomization was performed in a 1:1 ratio using the propensity score matching method, after which 30 patients were included in each group. The primary endpoint was the development of predementia/dementia. Results: In the group patients with asymptomatic cerebral ischemic lesions, both a significantly lower median score on the MMSE test (26 [25; 28] versus 28 [28; 29], p < 0.001) and a greater number of patients with dementia/predementia (18 (60%) versus 7 (23.3%), p = 0.008) were found compared with the control group in 12 months after CAS. Asymptomatic cerebral ischemic lesions increased the risk of developing predementia/dementia within 12 months after CAS (RR 2.57 [1.07; 6.15], p = 0.02). The total volume of asymptomatic cerebral ischemic lesions ≥ 78 mm3 predicted a decline in cognitive functions. Conclusion: Asymptomatic cerebral ischemic lesions after CAS significantly increased the risk of developing cognitive impairment during 12 months after procedure. Received 20 February 2025. Revised 6 March 2025. Accepted 7 March 2025. FundingThe study did not have sponsorship. Conflict of interestThe authors declare no conflict of interest. Contribution of the authorsConception and study design: O.S. Osipova,A.A. Gostev, S.V. Bugurov, P.V. Ignatenko, A.M. ChernyavskiyData collection and analysis: O.S. Osipova, A.A. Gostev, S.V. BugurovStatistical analysis: O.S. Osipova, A.A. Gostev, S.V. BugurovDrafting the article: O.S. Osipova, A.A. GostevCritical revision of the article: P.V. Ignatenko,A.M. ChernyavskiyFinal approval of the version to be published: O.S. Osipova, A.A. Gostev, S.V. Bugurov, P.V. Ignatenko, A.M. Chernyavskiy
- Open Access
- 6 July 2022
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 21 (7) , 3183
Chronic mesenteric ischemia: causes, methods of diagnosis and treatment
Chronic mesenteric ischemia (CMI) is an urgent public health problem. The long asymptomatic course of the disease, sudden onset and an unfavorable prognosis in the absence of treatment make it necessary to pay closer attention to this pathology. There are currently two competitive treatments for CMI: surgical and endovascular revascularization. Despite numerous studies comparing these methods, the question of which one is more effective and reliable remains open. The review includes current data from clinical trials and meta-analyses demonstrating the advantages and disadvantages of both methods.
- 6 July 2022
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 21 (7) , 3183
Open AccessChronic mesenteric ischemia: causes, methods of diagnosis and treatment
Chronic mesenteric ischemia (CMI) is an urgent public health problem. The long asymptomatic course of the disease, sudden onset and an unfavorable prognosis in the absence of treatment make it necessary to pay closer attention to this pathology. There are currently two competitive treatments for CMI: surgical and endovascular revascularization. Despite numerous studies comparing these methods, the question of which one is more effective and reliable remains open. The review includes current data from clinical trials and meta-analyses demonstrating the advantages and disadvantages of both methods.
- Open Access
Impact of shaggy aorta on intraoperative cerebral embolism during carotid artery stenting
Background Careful selection of patients for carotid stenting is necessary. We suggest that patients with a shaggy aorta syndrome may have a higher risk of perioperative embolic complications. Methods The study is a subanalysis of the SIBERIA Trial. We included 72 patients undergoing transfemoral carotid artery stenting. All patients had an MRI DWI and a clinical neurological examination two days before and on the second and 30th days after the intervention. Results 46 patients had shaggy aorta syndrome. Intraoperative embolisms were recorded in 82.6% and 46.1% of patients with and without shaggy aorta syndrome, respectively (p=0.001). New asymptomatic ischemic brain lesions in the postoperative period occurred in 78.3% and in 26.9% of patients with and without shaggy aorta syndrome, respectively (p=0.000). 3 (6.5%) cases of stroke within 30 days after the procedure were observed only in patients with shaggy aorta syndrome. Shaggy aorta syndrome (OR 5.54 [1.83:16.7], p=0.001) and aortic arch ulceration (OR 6.67 [1.19: 37.3], p = 0.02) were independently associated with cerebral embolism. Shaggy aorta syndrome (OR 9.77 [3.14-30.37], p=0.000) and aortic arch ulceration (OR 12.9 [2.3: 72.8], p = 0.003) were independently associated with ipsilateral new asymptomatic ischemic brain lesions. Conclusions Shaggy aorta syndrome and aortic arch ulceration significantly increase the odds of intraoperative embolism and new asymptomatic ischemic brain lesions. Carotid endarterectomy or transcervical carotid stent should be selected in the presence of aortic ulceration.
Open AccessImpact of shaggy aorta on intraoperative cerebral embolism during carotid artery stenting
Background Careful selection of patients for carotid stenting is necessary. We suggest that patients with a shaggy aorta syndrome may have a higher risk of perioperative embolic complications. Methods The study is a subanalysis of the SIBERIA Trial. We included 72 patients undergoing transfemoral carotid artery stenting. All patients had an MRI DWI and a clinical neurological examination two days before and on the second and 30th days after the intervention. Results 46 patients had shaggy aorta syndrome. Intraoperative embolisms were recorded in 82.6% and 46.1% of patients with and without shaggy aorta syndrome, respectively (p=0.001). New asymptomatic ischemic brain lesions in the postoperative period occurred in 78.3% and in 26.9% of patients with and without shaggy aorta syndrome, respectively (p=0.000). 3 (6.5%) cases of stroke within 30 days after the procedure were observed only in patients with shaggy aorta syndrome. Shaggy aorta syndrome (OR 5.54 [1.83:16.7], p=0.001) and aortic arch ulceration (OR 6.67 [1.19: 37.3], p = 0.02) were independently associated with cerebral embolism. Shaggy aorta syndrome (OR 9.77 [3.14-30.37], p=0.000) and aortic arch ulceration (OR 12.9 [2.3: 72.8], p = 0.003) were independently associated with ipsilateral new asymptomatic ischemic brain lesions. Conclusions Shaggy aorta syndrome and aortic arch ulceration significantly increase the odds of intraoperative embolism and new asymptomatic ischemic brain lesions. Carotid endarterectomy or transcervical carotid stent should be selected in the presence of aortic ulceration.
- Open Access
- 7 April 2022
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 37 (1) , 96-107
Comparative retrospective analysis of the results of open femoral-popliteal bypass grafting and endovascular stenting with an interwoven biomimetic stent in patients with prolonged occlusions of the arteries in the femoropopliteal segment
Introduction. Autovenous graft is considered the gold standard for prolonged occlusive lesions of the arteries in the femoralpopliteal segment. However, the vein is not always anatomically suitable for bypass grafting; it may have been previously used in previous operations, for example, in coronary artery bypass grafting. Open surgery is always more traumatic than endovascular surgery. Conventional nitinol stents show unsatisfactory results in the femoral-popliteal position due to the high percentage of reocclusions associated with their breakage during physiological movements in the leg joints. The modified method of making interwoven nitinol stents allows improving their biomimetic properties and reducing the percentage of breakages and, accordingly, reocclusions.Material and Methods. There was a retrospective analysis of 437 patients with prolonged atherosclerotic occlusive lesion in the femoropopliteal segment (> 20 cm). There were two groups: a group of bypass surgery and a group of endovascular intervention. The pseudo-randomization method of propensity score matching was used to align the groups according to various criteria.Results. Primary and secondary patency rates for one- and two-year follow up were comparable between the two groups. A subgroup analysis of above-knee intervention showed that a two-year secondary patency rate was significantly higher in the endovascular intervention group than in the bypass group (90.9% vs. 77.5%, p = 0.048). The subgroup analysis of interventions below the knee joint showed that the patency rates at two years of primary and primary-assisted patency were significantly higher in the endovascular intervention group than in the bypass group with an artificial expanded polytetrafluoroethylene (ePTFE) graft (66.7% versus 42.4%, p = 0.046 and 76.7% versus 45.5%, p = 0.011, respectively). The autovenous graft showed better results for primary patency compared with the endovascular intervention group, but the difference was statistically insignificant (77.2% versus 66.7%, respectively, p = 0.3).Conclusion. The analysis of obtained results suggests that the primary endovascular strategy may be recommended for all prolonged occlusive lesions of the femoropopliteal segment above the knee joint gap. For lesions below the knee joint, the autovenous bypass grafting remains the operation of choice, but in the absence of a suitable autovenous graft, the primary endovascular strategy may also be recommended. Additional large multicenter randomized trials are required to refine these recommendations.
- 7 April 2022
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 37 (1) , 96-107
Open AccessComparative retrospective analysis of the results of open femoral-popliteal bypass grafting and endovascular stenting with an interwoven biomimetic stent in patients with prolonged occlusions of the arteries in the femoropopliteal segment
Introduction. Autovenous graft is considered the gold standard for prolonged occlusive lesions of the arteries in the femoralpopliteal segment. However, the vein is not always anatomically suitable for bypass grafting; it may have been previously used in previous operations, for example, in coronary artery bypass grafting. Open surgery is always more traumatic than endovascular surgery. Conventional nitinol stents show unsatisfactory results in the femoral-popliteal position due to the high percentage of reocclusions associated with their breakage during physiological movements in the leg joints. The modified method of making interwoven nitinol stents allows improving their biomimetic properties and reducing the percentage of breakages and, accordingly, reocclusions.Material and Methods. There was a retrospective analysis of 437 patients with prolonged atherosclerotic occlusive lesion in the femoropopliteal segment (> 20 cm). There were two groups: a group of bypass surgery and a group of endovascular intervention. The pseudo-randomization method of propensity score matching was used to align the groups according to various criteria.Results. Primary and secondary patency rates for one- and two-year follow up were comparable between the two groups. A subgroup analysis of above-knee intervention showed that a two-year secondary patency rate was significantly higher in the endovascular intervention group than in the bypass group (90.9% vs. 77.5%, p = 0.048). The subgroup analysis of interventions below the knee joint showed that the patency rates at two years of primary and primary-assisted patency were significantly higher in the endovascular intervention group than in the bypass group with an artificial expanded polytetrafluoroethylene (ePTFE) graft (66.7% versus 42.4%, p = 0.046 and 76.7% versus 45.5%, p = 0.011, respectively). The autovenous graft showed better results for primary patency compared with the endovascular intervention group, but the difference was statistically insignificant (77.2% versus 66.7%, respectively, p = 0.3).Conclusion. The analysis of obtained results suggests that the primary endovascular strategy may be recommended for all prolonged occlusive lesions of the femoropopliteal segment above the knee joint gap. For lesions below the knee joint, the autovenous bypass grafting remains the operation of choice, but in the absence of a suitable autovenous graft, the primary endovascular strategy may also be recommended. Additional large multicenter randomized trials are required to refine these recommendations.
- Open Access
One-year results of long femoropopliteal lesions stenting with fasciotomy lamina vastoadductoria
Objective Fasciotomy can increase the mobility of the superficial femoral artery and reduce the incidence of stent breakage. This study aimed to compare the long-term patency of drug-eluting nitinol stents with and without fasciotomy in patients with prolonged SFA occlusions. Methods A randomized clinical trial was conducted in 60 (1:1) patients with long femoropopliteal steno-occlusive lesions more than 200 mm. Patients in group 1 (Zilver) underwent recanalization of occlusion of the femoropopliteal artery with stenting. In group 2 (ZilverFas), recanalization of the femoropopliteal occlusion with stenting and fasciotomy of Gunter’s canal were performed. The follow up evaluation of patency at 6, 12 months. Results 12-month primary patency in Zilver and ZilverFas groups was 51% and 80%, respectively (p = 0.02). The freedom from target revascularization (TLR) in Zilver and ZilverFas groups was 50% and 76%, respectively (p = 0.04). At one-years, primary-assisted and secondary patency for the ZilverFas and Zilver groups were 83% versus 62% (p = 0.07), 86% versus 65% (p = 0.05), respectively. In groups Zilver and ZilverFas, the number of stents fracture was 14 and 7, respectively (p = 0.05). The Cox multivariables regression indicated that the stent fracture, diabetes mellitus were the independent predictor of restenosis and reocclusion. Fasciotomy reduced the chance of reocclusion and restenosis by 2.94 times. Conclusions Our study has shown that a decompressing the stented segment with fasciotomy significantly improves the patency of the femoropopliteal segment and significantly reduces the number and severity of stents fractures.
Open AccessOne-year results of long femoropopliteal lesions stenting with fasciotomy lamina vastoadductoria
Objective Fasciotomy can increase the mobility of the superficial femoral artery and reduce the incidence of stent breakage. This study aimed to compare the long-term patency of drug-eluting nitinol stents with and without fasciotomy in patients with prolonged SFA occlusions. Methods A randomized clinical trial was conducted in 60 (1:1) patients with long femoropopliteal steno-occlusive lesions more than 200 mm. Patients in group 1 (Zilver) underwent recanalization of occlusion of the femoropopliteal artery with stenting. In group 2 (ZilverFas), recanalization of the femoropopliteal occlusion with stenting and fasciotomy of Gunter’s canal were performed. The follow up evaluation of patency at 6, 12 months. Results 12-month primary patency in Zilver and ZilverFas groups was 51% and 80%, respectively (p = 0.02). The freedom from target revascularization (TLR) in Zilver and ZilverFas groups was 50% and 76%, respectively (p = 0.04). At one-years, primary-assisted and secondary patency for the ZilverFas and Zilver groups were 83% versus 62% (p = 0.07), 86% versus 65% (p = 0.05), respectively. In groups Zilver and ZilverFas, the number of stents fracture was 14 and 7, respectively (p = 0.05). The Cox multivariables regression indicated that the stent fracture, diabetes mellitus were the independent predictor of restenosis and reocclusion. Fasciotomy reduced the chance of reocclusion and restenosis by 2.94 times. Conclusions Our study has shown that a decompressing the stented segment with fasciotomy significantly improves the patency of the femoropopliteal segment and significantly reduces the number and severity of stents fractures.
- Open Access
- 26 January 2022
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 21 (2) , 3085
Relationship of pharmacotherapy and the incidence of embolic complications of carotid reconstructive surgery
Aim . To evaluate the relationship between lipid-lowering and antiplatelet therapy and the incidence of cerebral microembolism and related complications in open and endovascular revascularization of the carotid arteries (CA). Material and methods . This single-center study involved patients with internal CA stenosis. The patients were divided into 2 groups depending on the surgery type performed: carotid endarterectomy (CEA) — 163 patients; CA stenting (CAS) — 71 patients. All patients underwent intraoperative transcranial Doppler monitoring to register cerebral embolism during CAS and CE. Results . In CAS, microembolism episodes were observed in 66,2% vs 22,1% of patients in the CEA group (p=0,04), the largest number of which was recorded during catheterization of the internal CA and embolic filter installation (p=0,000). There were no significant differences between the groups in terms of the stroke incidence. In 8 patients in the CAS group and 1 patient in the CEA group, a transient ischemic attack was observed within 30 days after surgery (p=4x10-4 ). Intraoperative embolism was a predictor of a neurological event in the early postoperative period (odds ratio (OR), 33,08; 95% confidence interval (CI): 3,49-56,37 (p6 months before surgery reduces the likelihood of embolism by 4 times (OR 0,25; 95% CI: 0,11-0,58 (p=0,001), while lipid-lowering and antiplatelet therapy combination — by 12,5 times (OR, 0,08; 95% CI: 0,01-0,40 (p=0,001)). Conclusion . Preoperative antiplatelet and statin therapy reduces the likelihood of embolism during the CA revascularization procedure.
- 26 January 2022
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 21 (2) , 3085
Open AccessRelationship of pharmacotherapy and the incidence of embolic complications of carotid reconstructive surgery
Aim . To evaluate the relationship between lipid-lowering and antiplatelet therapy and the incidence of cerebral microembolism and related complications in open and endovascular revascularization of the carotid arteries (CA). Material and methods . This single-center study involved patients with internal CA stenosis. The patients were divided into 2 groups depending on the surgery type performed: carotid endarterectomy (CEA) — 163 patients; CA stenting (CAS) — 71 patients. All patients underwent intraoperative transcranial Doppler monitoring to register cerebral embolism during CAS and CE. Results . In CAS, microembolism episodes were observed in 66,2% vs 22,1% of patients in the CEA group (p=0,04), the largest number of which was recorded during catheterization of the internal CA and embolic filter installation (p=0,000). There were no significant differences between the groups in terms of the stroke incidence. In 8 patients in the CAS group and 1 patient in the CEA group, a transient ischemic attack was observed within 30 days after surgery (p=4x10-4 ). Intraoperative embolism was a predictor of a neurological event in the early postoperative period (odds ratio (OR), 33,08; 95% confidence interval (CI): 3,49-56,37 (p6 months before surgery reduces the likelihood of embolism by 4 times (OR 0,25; 95% CI: 0,11-0,58 (p=0,001), while lipid-lowering and antiplatelet therapy combination — by 12,5 times (OR, 0,08; 95% CI: 0,01-0,40 (p=0,001)). Conclusion . Preoperative antiplatelet and statin therapy reduces the likelihood of embolism during the CA revascularization procedure.
- Open Access
- 6 April 2021
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 36 (1) , 30-37
Outcomes of using various designs of carotid stents
Исходы применения различных конструкций каротидных стентов
- 6 April 2021
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 36 (1) , 30-37
Open AccessOutcomes of using various designs of carotid stents
Исходы применения различных конструкций каротидных стентов
- Open Access
- 21 April 2020
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 19 (2)
Modern approaches to femoropopliteal bypass surgery: achievements and future prospects
Современные подходы к реваскуляризации бедренно-подколенных поражений. Достижения и перспективы
- 21 April 2020
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 19 (2)
Open AccessModern approaches to femoropopliteal bypass surgery: achievements and future prospects
Современные подходы к реваскуляризации бедренно-подколенных поражений. Достижения и перспективы